A micro-robotic platform developed for minimally invasive ultra-selective microsurgical procedures and targeted drug delivery; Dr. WIlliam Loudon;

  • Rate This

SUMMARY: With a team of global scientists, Dr. William Loudon, a Pediatric Neurosurgeon, has developed  a unique method of guiding a Mircorobotic device in the CSF pathways to enter the brain tissue and to reach defined targets throughout the CNS for tissue sampling or potential drug delivery at the cellar source of this pathology. This work, done in sheep, is compared to using traditional neurosurgical catheters targeting similar locations in humans. In detailed histological studies, the authors find that there is no difference in tissue damage using the Bionaut (robotic device) compared with catheter use. This pioneering work opens the potential of using this system to obtain tissue samples and for delivering a targeted drug payload to cells. For example, it could be used in obtaining brain stem tissue  samples of tumors or to  delivering local therapeutics.  This research has wide implications in Surgery and Medicine. We look forward to to more publications from Dr. Loudon on this pioneering work. 63 min. (JIA) PRINT

Speaker
  • Williiam Loudon, MD, PhD

    Section Chief, Division of Neurosurgery, Children's Hospital of Orange County/Rady Children's Health Network